Featured image: PaceMate at HRS - Read full post: Recap: PaceMate at HRS 2025: Innovations in Cardiac Remote Monitoring

Recap: PaceMate at HRS 2025: Innovations in Cardiac Remote Monitoring

PaceMate participated in the Heart Rhythm Society (HRS) 2025 Annual Scientific Sessions in San Diego, which brings together healthcare professionals, researchers, and industry leaders to discuss key developments in cardiac remote monitoring. Here are the highlights.

New Releases

At HRS 2025, we were excited to announce our Proprietary PaceArt Historic Data Migration Tool, offering PaceArt customers the exclusive capability to migrate their historical PaceArt data to PaceMateLIVE—our next-generation, cloud-based platform built for the future of cardiac data management.

Built by the workflow experts and developers you already rely on, it's the cleanest, most complete transition path to the cloud. It's more than an upgrade. It's the transition you can trust. Learn more here.

Sue Davish, Clinical Program Coordinator at PaceMate Accepts IBHRE 2025 Ambassador of the Year Award

Sue Davish (1)We’re thrilled to share that Susan Davish, MSN, RN, CCDS, Testamur, CDRMS, has officially accepted the IBHRE 2025 Ambassador of the Year Award!

From leading with compassion to pioneering excellence in cardiac remote monitoring, Sue continues to set the bar high—not just on PaceMate's Clinical Monitoring Services Team, but across the entire digital healthcare community. This award commends her dedication, leadership, and the meaningful impact she makes every day.

 

 

PaceMate’s Research Capabilities Showcased at 2025 Heart Rhythm Scientific Sessions

Two studies presented at the 2025 Heart Rhythm Scientific Sessions leveraged PaceMate data to investigate meaningful scientific questions.

ILR detected true asystole event unlikely to result in upgrade to a pacing capable device.

The study, “True asystole events on an ILR: Does that mean a pacemaker follows?”, (Middeldorp et al., 2025) examined the incidence and characteristics that led to the implant of a pacing-capable device after a true positive pause was detected via an ILR. The study found that 10,405 true asystole events were detected from 1354 patients during a mean follow up period of 1.9 +/- 1.1 years. Of those patients, 19.8% underwent an upgrade from ILR to a pacing-capable device. This data suggests that there are additional criteria in addition to the true asystole event that determined the need for upgrade to a pacing-capable device.

CIED Longevity Varies by Institution: A Call for CIED Registries, Benchmarking and Quality Improvement

Leveraging the data from the “Implantable Cardioverter-Defibrillator Battery Longevity” study (Freeman et al., 2024) and “Variation in Pacemaker Battery Longevity” (Freeman, et al., 2024), Evans et al., studied institutional factors that may impact device longevity. The earlier studies found that the parameters strongly associated with ICD battery longevity included vendor, device type, programmed pulse width and programmed output and the parameters most closely associated with pacemaker battery longevity included pacing percentage, programmed output, programmed pulse width, impedance, device type and although not consistent, vendor. Similarly, follow up center is also a variable for CIED longevity.

The “Centralised Remote Monitoring Reveals Institutional Variability in CIED Longevity”, a retrospective study that examined CIED battery longevity across 81 anonymized, unique device clinics found significant variability in CIED longevity across clinics. Among the study population, the investigators found that device implant volume was a weak predictor of longevity for ICDs and a moderate predictor of longevity for pacemakers. However, low longevity outliers aligned with low model specific volumes (less than 50 specific models). The authors recommend the establishment of national and international registries to track real world CIED performance. Benchmarking and QI could address disparities in care as well as improve CIED longevity, reduce frequency of device replacement, improve patient outcomes and ultimately lower healthcare utilization and costs.

See You Next Year

The PaceMate team loved connecting with everyone who stopped by our booth. We're excited to continue to bring you new innovations at HRX 2025.

Back to Blog